What is the future outlook for research on HER3 and HER4 in cancer?
The future of research on HER3 and HER4 in cancer looks promising. Advances in genomic and proteomic technologies are helping to elucidate the specific alterations and roles of these receptors in various cancers. This knowledge will aid in the development of more precise and effective targeted therapies. Additionally, ongoing clinical trials are likely to provide valuable insights into the efficacy and safety of HER3 and HER4 inhibitors, potentially leading to new treatment options for patients.
